51成人动漫

Dermatology >

Psoriasis

News, opinions and meeting coverage in dermatology.

Telemedicine OK for Psoriasis Care

Outcomes didn't differ in randomized trial

Psoriasis Falls to Novel Biologic

Bimekizumab brings clear or almost clear skin to vast majority of patients in phase II trial

Risankizumab Resolves Psoriasis in Half of Patients

Superior to ustekinumab for many endpoints in two RCTs

AAD 2018: Emphasis on 'Adult' Education, Engagement

More hands-on sessions, direct participant involvement

Selective IL-23 Inhibitor Shines in Mid-Stage PsA Trial

Risankizumab broadly effective against joint and skin symptoms

Psoriasis Responds After Biologic Failure

PASI-75 rate exceeds 80% with tildrakizumab

Cimzia Passes Muster in Two Psoriasis Trials

Met primary efficacy goals versus placebo; third trial still to come

One Biologic Bests Another in Head-to-Head Psoriasis Trial

Taltz turns in better results than Stelara on severity indices

Make the Diagnosis:聽Callus Conundrum

Case Findings: A 52-year-old man presents with possible calluses on either side of his thumb, forefinger, and middle finger. He reports cutting them off with nail clippers, but they return. He also reports using an over-the-counter wart treatment without success. What is your diagnosis?

Pearls From: Rheumatologist Philip Mease

An expert discusses new treatments for PsA and SpA

Make the Diagnosis: More Than A Rash

Case Findings: A 51-year-old woman visited her primary care doctor complaining of a rash, pruritus, myalgias, and muscle weakness that made normally easy tasks like standing from a seated position difficult. The rash was an erythematous blanching patch, spread across her back and shoulders like a shawl and across her chest in a V shape. She had also noticed that her fingernail folds were red and swollen. What is your diagnosis?

Anti-IL17A Tx Clears Most Cases of Psoriasis

Durable long-term responses with ixekizumab, secukinumab

A Tale of Two Psoriasis Numbers: PASI 75 or 90?

Debate over complete clearance goals ends in draw

Biogen Reports Another Tecfidera PML Case

Non-fatal case is the second one for the oral MS drug.

Stelara Eases Spine Symptoms in PsA

Improvements with ustekinumab maintained for 2 years

Sex Life Suffers with Psoriasis 'Down There'

Quality of life takes a hit from genital involvement.

AAD: Frog Enzyme Clears Genital Warts

Summaries of late-breaking research from the dermatology meeting.

Psoriasis and Tonsillectomy: A Real Head Scratcher

Skin disease often improves after surgery but no one knows why.

IL-17 Inhibitor Clears Psoriasis More Often

Brodalumab twice as likely to clear all lesions as ustekinumab.

Novel IL-23 Inhibitor Shows Promise in Psoriasis

Interleukin-23 inhibitor has 'high efficacy, quiet safety signal.'

Cosentyx Gets FDA Nod for Psoriasis

Anti-IL17 drug secukinumab OK'd for moderate-to-severe disease.

Otezla Benefit Durable in PsA

Benefits persist through 2 years with apremilast in psoriatic arthritis.

Derms Want NP/PA Practice Limits

NPs and PAs who bill Medicaid as independent practitioners are more likely to bill for a dermatology visit than for any other office-based service -- so much so that in 2012, 55% of their Medicaid billings were for derm codes, to which dermatologists claim scope of practice violations.

Smoking Worsens Psoriatic Arthritis

Patients with psoriatic arthritis who smoke have worse patient-reported disease features at baseline and don't respond as well as nonsmokers to anti-tumor necrosis factor (TNF) treatment, a Danish study found.

Prime Time: Skin Docs Name 5 Unnecessary Procedures

The American Academy of Dermatology joined more than 80 other medical societies in the Choosing Wisely campaign, naming five treatments or procedures that may not be necessary. Prime Time is a blog by Chris Kaiser for those interested in primary care.

Few Lupus, IBD Patients Getting HPV Vaccine

SAN DIEGO -- Despite being at greater risk of infection, few children and young adults with autoimmune diseases are being vaccinated against human papillomavirus, according to a study.

Novel Drug Works in Psoriasis

MIAMI BEACH -- An investigational phosphodiestirase-4 (PDE4) inhibitor may improve psoriasis, particularly in patients who haven't previously been treated, researchers reported here.

EADV: Psoriasis Comorbidities May Cut Longevity

BERLIN -- Psoriasis patients have a substantial comorbidity burden that can reduce life expectancy by 10 years or more, according to data presented here.

ICD: Herpes Virus Linked to Psoriasis

PRAGUE -- More than half of a group of patients with psoriasis tested positive for human herpes virus 8 (HHV-8), suggesting infection might play a role in the etiology of the disease, according to data reported here.

IBD Patients Prone to Other Autoimmune or Inflammatory Disorders

PHILADELPHIA-Patients with the inflammatory bowel disorders ulcerative colitis and Crohn's disease are significantly more likely to suffer from other conditions with an inflammatory or autoimmune basis, said researchers in two separate studies.